Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2025-07-01
DOI
https://doi.org/10.1186/s12885-025-14500-6
Primary Topic
Cancer therapeutics and mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study

Thomas Böhm, Liselot Valkenburg‐van Iersel, Matthew R. Redinbo, Ella M. Russ et al.
BMC Cancer
Cancer therapeutics and mechanisms
article

Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study

Thomas Böhm, Liselot Valkenburg‐van Iersel, Matthew R. Redinbo, Ella M. Russ, H Vestjens, Marjolein Louisa Smidt, A. Goosens, Judith de Vos‐Geelen, Tineke E. Buffart, Lars E. Hillege, John Penders, Janine Ziemons, Clara C. Elbers, Lee C. Vermeulen, Lauri Borghuis, Irene E.G. van Hellemond, Anne-Marie Dietvorst, E.M.G.J. de Jong, Maarten J. Deenen, Sander M. J. van Kuijk, A. Baars, P. Kristen, Leonieke Valk
article en

Abstract

No abstract available for this paper.
BMC CancerVol. 25(1)
University of North Carolina at Chapel Hill (US), Radboud University Nijmegen (NL), Leiden University Medical Center (NL), Maastricht University Medical Centre (NL), Catharina Ziekenhuis (NL), Bethesda Hospital (IN), Maastricht University (NL), Rode Kruis Ziekenhuis (NL), Oncode Institute (NL), VieCuri Medisch Centrum (NL), Ziekenhuis Gelderse Vallei (NL), Amsterdam University Medical Centers (NL), Cancer Center Amsterdam (NL), University of Amsterdam (NL), Wageningen University & Research (NL)
Danone, Universiteit Maastricht, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Maastricht Universitair Medisch Centrum, Dutch Colorectal Cancer Group, National Institutes of Health, Wageningen University and Research
Openalex Percentile: Top 86%
Cancer therapeutics and mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.